Microba Life Sciences Limited announced that Sonic Healthcare Limited has agreed to invest $17.8 million to acquire a 19.99% shareholding in Microba. In addition, Sonic is seeking to acquire options for an additional 5% equity position, subject to shareholder approval. Exercise of the options by Sonic would result in a further investment of $7.5 million in Microba. With the two companies' united strategic objectives to bring cutting-edge microbiome testing into routine healthcare, Sonic Healthcare's Group Chief Medical Officer, Dr. Stephen Fairy, will join Microba's Medical Advisory Board, responsible
for governing the medical and scientific direction of Microba's commercial activities. Dr. Fairy will join a high-profile group of medical professionals on Microba's Medical Advisory Board comprising Prof. Ian Frazer (AC), Prof. Paul Griffin, Prof. Jake Begun and Dr. Chris Hogan (OAM). Sonic will not currently seek a position on Microba's Board of Directors.